Please try another search
Triumph Science & Technology Co.,Ltd reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 1,263.19 million compared to CNY 1,269.29 million a year ago. Net income was CNY 13.78 million compared to CNY 30.52 million a year ago. Basic earnings per share from continuing operations was CNY 0.0146 compared to CNY 0.0323 a year ago. Diluted earnings per share from continuing operations was CNY 0.0146 compared to CNY 0.0323 a year ago.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 1644.17 | 1467.51 | 1238.4 | |
Gross Profit | 197.15 | 197.35 | 159.2 | |
Operating Income | 93.2 | 99.59 | 44.88 | 11.32 |
Net Income | 22.01 | 44.59 | 29.47 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 10233.35 | 10558.45 | 9985.81 | 9825.47 |
Total Liabilities | 6073.07 | 5452.16 | 5317.1 | |
Total Equity | 4485.38 | 4533.65 | 4508.37 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -23.34 | -54.19 | 190.65 | 20.33 |
Cash From Investing Activities | -633.62 | 255.27 | -5.93 | -50.31 |
Cash From Financing Activities | -173.81 | 93.6 | -65.03 | 58.1 |
Net Change in Cash | -831.75 | 297.31 | 127.14 | 31.78 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review